[
    "A, and the dosage of the buffer A is as follows: the volume of the fermentation liquor and the volume of the buffer A are 1-100: 1, preferably 10: 1;</p><p id=\"p0034\" num=\"0034\">the cleaning agent may be a urea solution, guanidine hydrochloride solution, Triton, buffer a, etc., preferably a urea solution, most preferably a 2M urea solution (which may contain 1% Triton) in amounts of: the volume of the fermentation liquor and the volume of 2M urea are 0.2-100: 1, preferably 1-15: 1;</p><p id=\"p0035\" num=\"0035\">the urea solution is preferably an 8M urea solution, in the amounts: the volume of the fermentation liquor and the volume of 8M urea are 0.2-100: 1, preferably 2-15: 1.</p><p id=\"p0036\" num=\"0036\">Further, in the step B, the separation and purification method comprises an ultrafiltration microfiltration membrane technology purification method, a column chromatography purification method, a salting-out method and a dialysis method.</p><p id=\"p0037\" num=\"0037\">Further, in the step B, the separation and purification method comprises the following steps:</p><p id=\"p0038\" num=\"0038\">(1) and (3) a dialysis method, namely purifying the crude protein solution obtained in the step A by a dialysis method to obtain the target protein BD-11 solution.</p><p id=\"p0039\" num=\"0039\">The dialysis bag may have a molecular weight cut-off of 0.5-10kD, preferably the dialysis bag has a molecular weight cut-off of 3.5-10kD, most preferably the dialysis bag has a molecular weight cut-off of 10 kD.</p><p id=\"p0040\" num=\"0040\">(2) And D, the ultrafiltration and microfiltration method is to purify the crude protein solution obtained in the step A by using membrane technologies such as an ultrafiltration membrane or a microfiltration membrane and the like to obtain the target protein BD-11 concentrated solution.</p><p id=\"p0041\" num=\"0041\">Preferably, the microfiltration membrane purification is carried out twice, wherein the first membrane aperture is 1000-1500 nm, and the second membrane aperture is 20-50 nm.</p><p id=\"p0042\" num=\"0042\">(3) The column chromatography method is that the crude protein solution obtained in the step A is separated and purified by column chromatography, such as various exchange columns or exclusion column chromatography, to obtain the target protein BD-11.</p><p id=\"p0043\" num=\"0043\">Preferred exclusion columns are sephadex columns, Superdex 30 Increase, Superdex 75 Increase, Superdex 200 Increase, Superose 6 Increase, etc.; preferred columns are ion exchange resin columns: anion exchange resin columns, HiTrap Q FF, HiTrap Capto Q Impres, HiTrap Capto Q, HiTrap DEAE, Toyopearl Q-650M, Toyopearl SuperQ-650M, and the like; cation exchange resin column, HiTrap SP FF, HiTrap Capto SP ImpRes, HiTrap Capto SP, Toyopearl SP-650M, Toyopearl Super SP-650M. Most preferred is an anion exchange resin column.</p><p id=\"p0044\" num=\"0044\">As the eluent, those commonly used in the art can be used, for example, water, salt solutions including sodium chlori",
    "he buffer solution is preferably buffer A, and the dosage of the buffer A is as follows: the volume of the fermentation liquor and the volume of the buffer A are 1-100: 1, preferably 10: 1;</p><p id=\"p0085\" num=\"0085\">the cleaning agent may be a urea solution, guanidine hydrochloride solution, Triton, buffer a, etc., preferably a urea solution, most preferably a 2M urea solution (which may contain 1% Triton) in amounts of: the volume of the fermentation liquor and the volume of 2M urea are 0.2-100: 1, preferably 1-15: 1;</p><p id=\"p0086\" num=\"0086\">the urea solution is preferably an 8M urea solution, in the amounts: the volume of the fermentation liquor and the volume of 8M urea are 0.2-100: 1, preferably 2-15: 1.</p><p id=\"p0087\" num=\"0087\">(6) Separating and purifying the target protein BD-11:</p><p id=\"p0088\" num=\"0088\">and (5) purifying the crude protein solution obtained in the step (5) to obtain the target protein BD-11. The purification may be performed by dialysis, or ultrafiltration microfiltration, or column chromatography, or a salting-out step.</p><p id=\"p0089\" num=\"0089\">A. And (3) a dialysis step, namely purifying the crude protein solution obtained in the step (5) by a dialysis method to obtain the target protein BD-11 solution.</p><p id=\"p0090\" num=\"0090\">The dialysis bag may have a molecular weight cut-off of 0.5-10kD, preferably the dialysis bag has a molecular weight cut-off of 3.5-10kD, most preferably the dialysis bag has a molecular weight cut-off of 10 kD.</p><p id=\"p0091\" num=\"0091\">B. And (3) an ultrafiltration microfiltration step, namely purifying the crude protein solution obtained in the step (5) by using membrane technologies such as an ultrafiltration membrane or a microfiltration membrane and the like to obtain a target protein BD-11 concentrated solution.</p><p id=\"p0092\" num=\"0092\">Preferably, the microfiltration membrane purification is carried out twice, wherein the first membrane aperture is 1000-1500 nm, and the second membrane aperture is 20-50 nm.</p><p id=\"p0093\" num=\"0093\">C. And (3) a step of column chromatography, namely separating and purifying the crude protein solution obtained in the step (5) by column chromatography, such as various exchange columns or exclusion column chromatography to obtain the target protein BD-11.</p><p id=\"p0094\" num=\"0094\">Preferred exclusion columns are sephadex columns, Superdex 30 Incrase, Superdex 75 Incrase, Superdex 200 Incrase, Superose 6 Incrase and the like; preferred columns are ion exchange resin columns: anion exchange resin columns, HiTrap Q FF, HiTrap Capto Q Impres, HiTrap Capto Q, HiTrap DEAE, Toyopearl Q-650M, Toyopearl SuperQ-650M, and the like; cation exchange resin column, HiTrap SP FF, HiTrap Capto SP ImpRes, HiTrap Capto SP, Toyopearl SP-650M, Toyopearl Super SP-650M. Most preferred is an anion exchange resin column.</p><p id=\"p0095\" num=\"0095\">As the eluent, those commonly used in the art can be used, for example, water, salt solutions including sodium",
    "0</sub>When OD is greater than<sub>600</sub>When the protein reaches about 1.0, adding an inducer, and inducing and expressing the protein in a shaking table under the inducing conditions selected from the following table.</p><p id=\"p0121\" num=\"0121\"></p><p id=\"p0122\" num=\"0122\">Combining the bacterial liquids in the bottles, centrifuging at 7000rpm for 5 minutes, and removing the supernatant after sterilizing; the pellet is suspended in about 3L of buffer, filtered through a 80-100 mesh screen, and the filtrate is disrupted by a high pressure disrupter at a pressure of 800-1000bar 2 times for 2 minutes each. The crushed bacteria liquid is centrifuged at 7000rpm for 30 minutes, and the supernatant is discarded to obtain a precipitate (i.e., inclusion bodies). Adding 1L cleaning agent into the precipitate, cleaning for 2 times, centrifuging, and discarding supernatant. The precipitate was dissolved in urea solution for 4 times (800 ml, 600ml, 400ml, respectively). The 4 solutions are combined, centrifuged at 7000rpm for 30 minutes, and the precipitate is discarded, and the supernatant is the crude protein solution A.</p><p id=\"p0123\" num=\"0123\"></p><p id=\"p0124\" num=\"0124\"></p><p id=\"p0125\" num=\"0125\">Analyzing the crude solution A of the protein BD-11 by using reduced SDS-PAGE, wherein the concentration of a separation gel is 12.5 percent, and staining is carried out by a Coomassie brilliant blue R250 method; a blue band was clearly observed at a molecular weight of about 59 kD.</p><p id=\"p0126\" num=\"0126\">EXAMPLE 2 Shake flask fermentation preparation of crude protein BD-11 solution B (other Medium)</p><p id=\"p0127\" num=\"0127\">In the embodiment 1, synthesizing and sequencing to obtain an expression vector containing a sequence shown as SEQ ID No. 2; the expression vector was transfected into BL21(DE3) cells to obtain expression competent host cells containing the nucleotide sequence of interest.</p><p id=\"p0128\" num=\"0128\">Prepare 20ml LB medium, take 800 u l, add containing target coding sequence of host cells 50 u l, in the shaking table, at 37 degrees C, 220rpm under the conditions of 1 hours.</p><p id=\"p0129\" num=\"0129\">The above-mentioned bacterial solution was dipped and streaked on LBA plates containing kanamycin, and the plates were placed upside down in a 37 \u2103 incubator overnight and cultured for 16 hours.</p><p id=\"p0130\" num=\"0130\">10ml of LB medium was added with Kanamycin (final concentration 50. mu.g/ml), and a single colony on the plate was added to LB medium and amplified overnight at 37 \u2103 and 220rpm for 15 hours in a shaker to obtain a seed solution.</p><p id=\"p0131\" num=\"0131\">1L of the medium shown in the following table was prepared and dispensed into 10 bottles of 100ml each. Kanamycin (final concentration 50. mu.g/ml) was added to each flask (100ml) of the medium, and 1ml of the seed solution was added thereto, followed by culturing in a shaker at 37 \u2103 and 220rpm for 2 to 3 hours. Monitoring OD<sub>600</sub>When OD is reach",
    "entry></row></tbody></tgroup></table></tables></p><p id=\"p0133\" num=\"0133\">Combining the bacterial liquids in the bottles, centrifuging at 10000rpm for 10 minutes, and removing the supernatant after sterilizing; the pellet was suspended in about 100mL of buffer, filtered through a 80-100 mesh screen, and the filtrate was disrupted using a high pressure disrupter at a pressure of 800 and 1000bar 2 times for 2 minutes each. And centrifuging the crushed bacteria liquid at 10000rpm for 30 minutes, and removing the supernatant.</p><p id=\"p0134\" num=\"0134\">Adding 40mL of cleaning agent buffer A into the precipitate, cleaning for 3 times, centrifuging, and removing the supernatant; adding 40mL of cleaning agent 2M urea solution into the precipitate, cleaning for 2 times, centrifuging, and removing supernatant; adding 40mL of 4M urea solution into the precipitate, cleaning for 2 times, centrifuging, and removing supernatant; dissolving the precipitate in 8M urea solution (containing 50mM Tris/HCl buffer) for 3 times (40 ml, 30 ml); the solution is combined, centrifuged at 7000rpm for 30 minutes, and the precipitate is discarded, and the supernatant is the crude protein solution B.</p><p id=\"p0135\" num=\"0135\">Analyzing the crude solution B of the protein BD-11 by using reduced SDS-PAGE, wherein the concentration of a separation gel is 12.5 percent, and staining is carried out by a Coomassie brilliant blue R250 method; a blue band was clearly observed at a molecular weight of about 59 kD.</p><p id=\"p0136\" num=\"0136\">EXAMPLE 3 fermenter preparation of crude solution C of protein BD-11</p><p id=\"p0137\" num=\"0137\">In the embodiment 1, synthesizing and sequencing to obtain an expression vector containing a sequence shown as SEQ ID No. 2; the expression vector was transfected into BL21(DE3) cells to obtain expression competent host cells containing the nucleotide sequence of interest. Adding into LB culture medium, culturing in shaker at 37 deg.C and 220rpm for 1 hr to obtain recombinant strain.</p><p id=\"p0138\" num=\"0138\">To the LBA plate containing Kanamycin, 100. mu.l of the recombinant strain was added, the spreader was spread to dry uniformly, and the plate was inverted and incubated overnight in a 37 \u2103 incubator. Taking three single colonies respectively, streaking on a plate containing kanamycin, culturing the plate overnight, after three batches of shake flask fermentation expression verification, preserving the strains with 15% glycerol, subpackaging into 0.8ml each to obtain a working cell bank, and freezing and storing in a refrigerator at-80 \u2103 for later use.</p><p id=\"p0139\" num=\"0139\">1 glycerol strain was taken out from the working cell bank, 100. mu.l of the glycerol strain was added to 40ml of LB medium, Kanamycin (final concentration: 50. mu.g/ml) was added thereto, and the mixture was cultured in a shaker at 37 \u2103 and 220rpm for 6 hours to obtain a primary seed solution.</p><p id=\"p0140\" num=\"0140\">Taking 1.2ml of the primary seed solution, add",
    "xygen at 30% (tandem rotation speed). OD was monitored at around 20, 3g of lactose was used as an inducer, induction was carried out at 20 \u2103 and feeding was carried out at a rate of 30 ml/hr, and incubation was carried out at 20 \u2103 for 24 hours.</p><p id=\"p0142\" num=\"0142\">Centrifuging the bacterial liquid at 7000rpm for 5 minutes, and removing the supernatant after sterilizing; the precipitate was suspended in about 200ml of buffer A, filtered through a 80-100 mesh screen, and the filtrate was crushed using a high pressure crusher at a pressure of 800-. The disrupted bacterial liquid is centrifuged at 7000rpm for 30 minutes, and the supernatant is discarded.</p><p id=\"p0143\" num=\"0143\">Adding 2M urea solution (containing 1% Triton) into the precipitate, and washing for 2 times, 1L each time; then 1L of 2M urea solution is added for cleaning for 1 time, and the supernatant is discarded after centrifugation. The precipitate was dissolved 4 times in 8M urea solution (400 ml, 300ml, 200ml, 100ml, respectively). And combining the four solutions, centrifuging at 7000rpm for 30 minutes, and discarding the precipitate to obtain a supernatant, namely the crude protein solution C.</p><p id=\"p0144\" num=\"0144\">Analyzing the crude solution C of the protein BD-11 by using reduced SDS-PAGE, wherein the concentration of the separation gel is 12.5 percent, and staining is carried out by a Coomassie brilliant blue R250 method; a blue band was clearly observed at a molecular weight of about 59 kD.</p><p id=\"p0145\" num=\"0145\">EXAMPLE 4 preparation of crude protein solution A protein BD-11 by dialysis</p><p id=\"p0146\" num=\"0146\">The crude protein solution A obtained in example 1 was filtered through a 0.45. mu. m l filter and the filtrates were combined. Dialyzing the filtrate with water, intercepting the molecular weight of 10kD in a dialysis bag, dialyzing for 72 hours, and freeze-drying the inner liquid to obtain the target protein BD-11; purity by electrophoresis was 83.6%.</p><p id=\"p0147\" num=\"0147\">And (3) confirming the structure of the protein BD-11:</p><p id=\"p0148\" num=\"0148\">1. analysis by reduced SDS-polyacrylamide gel electrophoresis (SDS-PAGE)</p><p id=\"p0149\" num=\"0149\">The instrument comprises the following steps: protein electrophoresis apparatus (Bio-Rad).</p><p id=\"p0150\" num=\"0150\">The method and the result are as follows: the BD-11 protein solution was analyzed by reduced SDS-PAGE and the gel concentration was 12.5% and stained by Coomassie Brilliant blue R250. The molecular weight of the BD-11 band is around 59 kD.</p><p id=\"p0151\" num=\"0151\">2. LC-MS/MS-based protein complete sequence analysis</p><p id=\"p0152\" num=\"0152\">The main materials are as follows: acetonitrile, formic acid, ammonium bicarbonate, Dithiothreitol (DTT), Iodoacetamide (IAA), trypsin, chymotrypsin, Glu-C, Asp-N;</p><p id=\"p0153\" num=\"0153\">the main apparatus is as follows: capillary HPLC (Thermo Ultimate model 3000), electrospray-combinatorial ion trap Orbitrap Mass Spectrometers (Thermo Q active Hybrid Quadrupole-Orbitrap Mass Spectrometers).</p><p id=\"p0154\" num=\"0154\">Methods and results:</p><p id=\"p0155\" num=\"0155\">carrying out pretreatment such as dissolving replacement, reductive alkylation, multiple proteolysis and the like on the protein BD-11 to obtain an enzyme digestion peptide segment; and (3) digesting the peptide fragment solution, performing liquid chromatography tandem mass spectrometry, searching the protein database analysis data by using Maxquant (1.6.2.10) in a mass spectrometry original file, and determining that the peptide fragment solution is consistent with the target sequence SEQ ID No.1 according to an identification result.</p><p id=\"p0156\" num=\"0156\">EXAMPLE 5 crude protein solution A protein BD-11 prepared by other methods of purification</p><p id=\"p0157\" num=\"0157\">The crude protein solution a obtained in example 1 was purified by the following two methods:</p><p id=\"p0158\" num=\"0158\">the first method comprises the following steps: salting out;</p><p id=\"p0159\" num=\"0159\">placing t"
]